Brief: Kali-Extracts Plans To Certify CBD Extract As OTC Drug Under FDA Requirements
10/09/2019 14:19
Sept 10 (Reuters) - Kali-Extracts Inc:
* KALI-EXTRACTS PLANS TO CERTIFY CBD EXTRACT AS OTC DRUG
UNDER FDA
REQUIREMENTS
Source text for Eikon: ID:nGNX5Gtgrn
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kali
See all newsBrief: KALY-Kali-Extracts RespRx Could Offer Treatment For Coronavirus Symptoms
Brief: Pura Explores Acquisition Of Kaly CBD Confection Assets
Brief: Kaly Confirms Consolidation Plans To Focus On $50 Bln Cannabis Biopharmaceutical Market Opportunity
Brief: Kali-Extracts Plans To Certify CBD Extract As OTC Drug Under FDA Requirements
Brief: Kali Says Co Receives Proposal To Certify Its CBD Extract As OTC Drug Under FDA Requirements